Investors / Germany / Apollo Health Ventures
Apollo Health Ventures
Venture capital · Berlin, Germany · Europe
Apollo Health Ventures is a transatlantic early-stage venture capital firm that co-founds and invests in healthcare companies. It combines traditional funding with venture building through its Venture Lab, which partners with scientific experts to turn technologies into companies.
Invests inHealthcare & Biotech
In its own wordsagingbiotechhealth techlongevityventure buildingdrug discovery
Your fit with Apollo Health Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsApollo Health Ventures lists 16 checked portfolio companies on its own site and is named in 4 funding rounds. Its most frequent entry is Seed, 25% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 39% of its companies are based in United States. It invests most often alongside Korify Capital, LifeLink Ventures and Sofinnova Partners.
Counts come from funding rounds that name Apollo Health Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Apollo Health Ventures' whole history. Rounds on record name 4 companies; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 25% |
| Series A | 25% |
| Series B | 25% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 42th | 16 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 60th | 25% of entries at pre-seed or seed |
| Evidence | 90th | 19% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 84th | 6 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Korify Capital | 5 |
| LifeLink Ventures | 2 |
| Sofinnova Partners | 2 |
| +ND Capital | 1 |
| ALS Investment Fund | 1 |
| AlbionVC | 1 |
| Athos Capital | 1 |
| BERNINA Bioinvest | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers16100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Apollo Health Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Apollo Health Ventures| Date | Company | Stage |
|---|---|---|
| 5 Mar 2026 | Series C+ | |
| 16 Dec 2025 | Series B | |
| 13 Nov 2025 | Seed | |
| 8 May 2025 | Series A |
Round details for Apollo Health Ventures
Amounts, full round histories and every co-investor in Apollo Health Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
16 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aeovian Pharmaceuticals develops small molecules to treat certain rare genetic and age-related diseases | Healthcare & Biotech | Dec 2025Series B | Page + round | |
| Auron Therapeutics targets cell state plasticity to improve patient outcomes in oncology and inflammatory disease | Healthcare & Biotech | Portfolio page | ||
| Bionyra Pharma is a clinical-stage biopharmaceutical company developing antibody therapies for immune-mediated inflammatory diseases such as atopic dermatitis and inflammatory bowel disease. | Healthcare & Biotech | Portfolio page | ||
| Bloom Science is a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Booster Therapeutics develops therapeutics to restore the cell's natural quality control machinery to treat complex diseases | Healthcare & Biotech | Portfolio page | ||
| Cleara Biotech is a biopharmaceutical research and development company focused on developing peptide-based therapies against cancer and chronic diseases. | Healthcare & Biotech | Portfolio page | ||
| Cognito Therapeutics is developing a non-invasive neuroprotective therapy platform to treat Alzheimer's disease and other neurodegenerative diseases | Healthcare & Biotech | Mar 2026Series C+ | Page + round | |
| Focal Biosciences is building a platform and pipeline to reprogram cells to a healthier state and deliver disease modifying medicines against chronic diseases. | Healthcare & Biotech | Portfolio page | ||
| Haya Therapeutics develops RNA-guided therapies to reverse disease-driving cell states and restore health. | Healthcare & Biotech | May 2025Series A | Page + round | |
| Nula Therapeutics is pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer | Healthcare & Biotech | Portfolio page | ||
| Ochre Bio develops novel medicines for liver disease using human data and AI models | Healthcare & Biotech | Portfolio page | ||
| Refoxy develops next-generation medicines to treat age-related diseases and extend the number of years people can live in good health. | Healthcare & Biotech | Portfolio page | ||
| Samsara Therapeutics is working on treating neurodegenerative diseases by improving autophagy. | Healthcare & Biotech | Portfolio page | ||
| Scripta Therapeutics develops drugs by modulating transcription factor activity to restore health | Healthcare & Biotech | Nov 2025Seed | Funding round | |
| Thymofox is developing targeted, orally available medicines for thymus regeneration | Healthcare & Biotech | Portfolio page | ||
| The company provides preventive medical check-ups and longevity services, including various health tests and analyses. | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- apollo.vc
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 8 May 2025
- Companies checked
- 16
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Apollo Health Ventures' profile as data
Pull Apollo Health Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/apollo.vc
# also
GET /v1/firms/apollo.vc/portfolio
GET /v1/firms/apollo.vc/coinvestors
GET /v1/firms/apollo.vc/news